Nimbus Therapeutics and Eli Lilly Expand Partnersh...
Category : Approval/Launch 9 January 2026Nimbus Therapeutics and Eli Lilly are doubling down on obesity drug innovation. The two companies...
Approval Launch
GSK Secures EC Approval for Shingrix in a Prefille...
Category : Approval/Launch 8 January 2026GSK has received European Commission (EC) approval for a new prefilled syringe presentation of Shing...
Oxeia Biopharmaceuticals Launches Equity Crowdfund...
Category : Approval/Launch 8 January 2026Oxeia Biopharmaceuticals has launched an equity crowdfunding campaign on StartEngine to accelerate d...
Sanofi and Regeneron receives Japanese marketing a...
Category : Approval/Launch 24 December 2025The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authoriz...
Indian Pharma Backs US FDA’s New Safety Reporting...
Category : Approval/Launch 22 December 2025Indian pharmaceutical companies have welcomed the US FDA’s latest guidance on safety reporting...
Latest Newsletter Post
-
Lilly’s TOGETHER-PsA Trial Shows Du..
9 January 2026
-
Muna Therapeutics Secures $1 Millio..
10 January 2026
-
Addex Spin-Out Neurosterix Begins P..
9 January 2026
-
Nimbus Therapeutics and Eli Lilly E..
9 January 2026
-
Oxeia Biopharmaceuticals Launches E..
8 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com